Abstract
people worldwide. Current treatment is only symptomatic and fails to control seizures in about 40% of patients. Gene therapy with NPY overexpression has emerged as an alternative treatment strategy for epilepsy, showing inhibitory effect on seizures in animal models. This effect seems to be mediated mostly via Y2 receptors, while Y1 receptor activation has an opposite outcome. To enhance NPY gene transfer effect on seizures, we additionally overexposed Y2 receipts using AAV vectors in the hippocampus of epileptic rats. We demonstrate that transgene Y2 receptors are functional and even potentiate transgene NPY effect on seizures. These data suggest that combinatorial NPY/Y2 gene therapy could be an alternative strategy to single NPY gene overexertion.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
